HomeSponsoredManaging and treating patients with VTEManaging VTE
Managing and treating patients with VTE
Managing VTE
This is promotional content, intended for UK healthcare professionals only. This webpage has been developed and funded by the Bristol-Myers Squibb / Pfizer Alliance.
Click here to view ELIQUIS® (apixaban) prescribing and adverse event reporting information.
This section addresses the management of patients with suspected VTE, including:
• Awareness of signs and symptoms of VTE
• Investigations for a suspected DVT
• Investigations for a suspected PE
Adverse events should be reported. Reporting forms and information can be found via United Kingdom – The yellow card scheme at www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (United Kingdom).